Add BrightSurf on Google Email

Study demonstrates rapid diagnosis of urinary tract infections with biosensor technology

A new biosensor developed by GeneFluidics enables accurate identification of bacteria in urine samples with a rapid turnaround time, reducing the two-day wait period for conventional lab tests. This innovation has the potential to improve patient outcomes and reduce healthcare costs associated with urinary tract infections.

SourceUniversity of California - Los Angeles·JournalJournal of Clinical Microbiology·DateFeb 2, 2006

Unraveling the viral mechanism

Researchers have made a breakthrough in understanding how viruses infect cells using cryoelectron microscopy and computational methods. The study reveals the importance of proteins beyond the surface shell in binding to host cells, injecting DNA, and packaging it during virus formation.

SourceBaylor College of Medicine·JournalNature·DateFeb 1, 2006

A step forward in the fight against bacterial infections

Researchers at VIB have discovered the mechanism behind reduced inflammation in mice, which produces just enough interferons to activate the immune system against bacteria. This finding is relevant to the quest for new therapeutics for bacterial infections and may provide a breakthrough in combating these deadly diseases.

SourceVIB (the Flanders Institute for Biotechnology)·JournalProceedings of the National Academy of Sciences·DateFeb 1, 2006

Patient safety monitoring at Hopkins Hospital finds law of unintended consequences at work

A Hopkins investigation found that a newly introduced catheter valve was linked to a spike in bloodstream infections in the pediatric intensive care unit. The team identified mechanical issues with the device as the likely source of infection, highlighting the need for closer monitoring of technology's safety.

SourceJohns Hopkins Medicine·JournalInfection Control and Hospital Epidemiology·DateJan 9, 2006

Infectious agent thwarts typical defense mechanisms; Sheds light on immune system function

Researchers discovered that Francisella tularensis can bypass the immune system's sensors and only triggers a response once inside a monocyte. This finding may lead to better treatments for diseases like tuberculosis and the plague. Understanding how the human immune system reacts to F. tularensis could provide new avenues for treatment.

SourceOhio State University·JournalProceedings of the National Academy of Sciences·DateDec 21, 2005

Gene increases risk of tuberculosis

A recent scientific study found that a specific gene variation on chromosome 17 is associated with an increased risk of developing active tuberculosis. The MCP-1 protein, which attracts immune cells to sites of infection, was found to play a crucial role in the early immune response to TB-causing bacteria.

SourceJournal of Experimental Medicine·JournalJournal of Experimental Medicine·DateDec 12, 2005

Markers found for bacterial vaginosis

Researchers have identified three newly recognized bacteria highly specific to bacterial vaginosis, a condition affecting up to 10% of pregnant women. The study aims to understand why lesbians and bisexual women are more likely to experience BV and develop strategies to prevent its recurrence.

SourceUniversity of Washington·JournalNew England Journal of Medicine·DateNov 7, 2005

'Good' bacteria could save patients from infection infection by deadlier ones

A new approach to fighting MRSA infections suggests allowing harmless bacteria to live in hospitals, creating a natural protection against more virulent strains. By doing so, antibiotic-free hospitals with 'good' bacteria can test the effectiveness of this method, potentially reducing the spread of deadly MRSA.

SourceThe Hebrew University of Jerusalem·JournalAnnals of The Royal College of Surgeons of England·DateNov 2, 2005

BCG vaccine effect against tuberculosis infection and disease

Researchers investigated risk factors for TB infection in 979 children from Istanbul, Turkey. They found that the absence of a BCG scar was a strong, independent risk factor for infection, while its presence reduced the risk by 24%. The study suggests that BCG vaccination also protects against TB infection, opening new avenues for deve...

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 12, 2005

Jefferson scientists design method to fight artificial implant infections with antibiotics

Researchers at Jefferson Medical College have developed a bonding method to create a permanent chemical bond between antibiotics and titanium, allowing it to kill bacteria and prevent infection. This technique has the potential to combat implant-related infections by creating an antibiotic surface that prevents infection from starting.

SourceThomas Jefferson University·JournalChemistry & Biology·DateSep 23, 2005

Troubling trends converge

Researchers report a disturbing convergence of drug-resistant bacteria and virulent new strains of Staph. aureus, leading to severe illness and death in previously healthy children. The study highlights the need for better treatments and a vaccine to combat this growing threat.

SourceUniversity of Chicago Medical Center·JournalNew England Journal of Medicine·DateSep 22, 2005

How bacteria break B cell tolerance

Researchers found that bacterial infections can activate self-reactive B cells with significant affinity, driving them to mature into harmful memory B cells. This activation is facilitated by the cooperation of autoantigens, innate immunity, and T cells.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 21, 2005

UT Southwestern professor supports development of report cards on hospital infection rates

A growing appetite for public reporting of hospital infection rates could lead to improved patient safety and quality of care. UT Southwestern professor Dr. Jane Siegel advocates for standardized reporting systems to track key metrics, but notes that challenges exist due to differences in patient populations and data collection methods.

SourceUT Southwestern Medical Center·JournalNew England Journal of Medicine·DateJul 20, 2005

The very defensive caterpillar

Researchers discovered that hawkmoth caterpillars infected with non-pathogenic bacteria produce antibacterial peptides that confer resistance against lethal insect pathogens. This finding suggests that field-immunized insects may exhibit different immune responses than laboratory models, challenging the validity of current studies.

Golden armor

Researchers found that a yellow-orange pigment produced by Staphylococcus aureus helps the bacteria resist neutrophil killing and produce disease. The discovery provides an novel target for treatment of serious Staph infections, including those caused by antibiotic-resistant MRSA.

SourceUniversity of California - San Diego·JournalJournal of Experimental Medicine·DateJul 11, 2005

Eliminating bacterial infections out of thin air

Researchers show that HIF-1 alpha regulates bactericidal agents and enhances expression of bacteria-killing cells. Increasing HIF-1 activity increases the killing capacity of phagocytes, providing a novel approach to treating bacterial infections.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 1, 2005